EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Complement contributes to antibody-mediated protection against repeated SHIV challenge

Benjamin S Goldberg iD, David A Spencer, Shilpi Pandey, Tracy Ordonez iD, Philip Barnette iD, Yun Yu iD, Lina Gao iD, Jérémy Dufloo iD, Timothée Bruel iD, Olivier Schwartz, Margaret E Ackerman iD, Ann J Hessell iD

Proceedings of the National Academy of Sciences · 16.05.2023 · 120 (20)

DOI: 10.1073/pnas.2221247120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 08.05.2023. Verfasst von Benjamin S Goldberg und 11 weiteren Autor:innen. Beteiligte Einrichtung: Thayer School of Engineering, Dartmouth College, Hanover, NH 03755. Hauptthemen laut MEDLINE: HIV Infections, Simian Acquired Immunodeficiency Syndrome, Simian Immunodeficiency Virus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, ODCDC CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The first clinical efficacy trials of a broadly neutralizing antibody (bNAb) resulted in less benefit than expected and suggested that improvements are needed to prevent HIV infection. While considerable effort has focused on optimizing neutralization breadth and potency, it remains unclear whether augmenting the effector functions elicited by broadly neutralizing antibodies (bNAbs) may also improve their clinical potential. Among these effector functions, complement-mediated activities, which can culminate in the lysis of virions or infected cells, have been the least well studied. Here, functionally modified variants of the second-generation bNAb 10-1074 with ablated and enhanced complement activation profiles were used to examine the role of complement-associated effector functions. When administered prophylactically against simian-HIV challenge in rhesus macaques, more bNAb was required to prevent plasma viremia when complement activity was eliminated. Conversely, less bNAb was required to protect animals from plasma viremia when complement activity was enhanced. These results suggest that complement-mediated effector functions contribute to in vivo antiviral activity, and that their engineering may contribute to the further improvements in the efficacy of antibody-mediated prevention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAnimalsBroadly Neutralizing AntibodiesMacaca mulattaViremiaComplement System ProteinsHIV AntibodiesAntibodies, Neutralizing

Stichwörter der Autor:innen

HIVantibody engineeringcomplement-dependent cytotoxicityeffector functionneutralizing antibody

Substanzen

Broadly Neutralizing AntibodiesComplement System ProteinsHIV AntibodiesAntibodies, Neutralizing

Autor:innen und Institutionen

  • Thayer School of Engineering, Dartmouth College, Hanover, NH 03755.
  • Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006.
  • Biostatistics Shared Resources, Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239.
  • Biostatistics & Bioinformatics Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
  • Institut Pasteur, Université de Paris, CNRS UMR3569, Virus and Immunity Unit, 75015 Paris, France.
  • Université de Paris, École doctorale BioSPC 562, 75013 Paris, France.

ORCID-Profile: Benjamin S Goldberg, Tracy Ordonez, Philip Barnette, Yun Yu, Lina Gao, Jérémy Dufloo, Timothée Bruel, Margaret E Ackerman, Ann J Hessell

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • ODCDC CDC HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Goldberg, B. S., Spencer, D. A., Pandey, S., Ordonez, T., Barnette, P., Yu, Y., Gao, L., Dufloo, J., Bruel, T., Schwartz, O., Ackerman, M. E., & Hessell, A. J. (2023). Complement contributes to antibody-mediated protection against repeated SHIV challenge. Proceedings of the National Academy of Sciences, 120(20). https://doi.org/10.1073/pnas.2221247120

Vancouver

Goldberg BS, Spencer DA, Pandey S, Ordonez T, Barnette P, Yu Y, et al. Complement contributes to antibody-mediated protection against repeated SHIV challenge. Proceedings of the National Academy of Sciences. 2023;120(20). doi:10.1073/pnas.2221247120

BibTeX
@article{Goldberg2023,
  author = {Goldberg, Benjamin S and Spencer, David A and Pandey, Shilpi and Ordonez, Tracy and Barnette, Philip and Yu, Yun and Gao, Lina and Dufloo, Jérémy and Bruel, Timothée and Schwartz, Olivier and Ackerman, Margaret E and Hessell, Ann J},
  title = {Complement contributes to antibody-mediated protection against repeated SHIV challenge},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {20},
  doi = {10.1073/pnas.2221247120}
}
Kostenlos starten →